Showing results (391-400 of 586) with videos related to

Sort By:
Pageof 59
Clinical Genetics|September 14, 2007
Movement and mood disorder in two brothers with Gaucher diseaseM Raja, A Azzoni, F Giona, et al.
Archives of Physiology and Biochemistry|December 1, 2015
Male mice are susceptible to high fat diet-induced hyperglycaemia and display increased circulatory retinol binding protein 4 (RBP4) levels and its expression in visceral adipose depotsG V Asha, M Raja Gopal Reddy, M Mahesh, et al.
Wiener Klinische Wochenschrift|March 6, 1987
[Right heart failure as a clinical sign of pulmonary artery sarcoma]P Bettelheim, M Hochmeister, C Herold, et al.
The Journal of Experimental Medicine|October 1, 1996
Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cellsK Geissler, L Ohler, M Födinger, et al.
Thrombosis and Haemostasis|November 2, 1999
Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V LeidenS Eichinger, A Weltermann, K Philipp, et al.
Bone Marrow Transplantation|September 1, 1994
Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humansM Hinterberger-Fischer, P Kier, J Spona, et al.
Blood|May 1, 1997
Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasiaF Keil, O A Haas, G Fritsch, et al.
Thrombosis and Haemostasis|January 4, 1998
Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolismP A Kyrle, A Stümpflen, M Hirschl, et al.
Bone Marrow Transplantation|November 9, 2004
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donorsH T Greinix, I Faé, B Schneider, et al.
Journal of the National Cancer Institute|April 21, 1993
Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study GroupH Döhner, A D Ho, J Thaler, et al.
Pageof 59